|Day's Range||52.56 - 55.06|
|52 Week Range||42.58 - 75.36|
|PE Ratio (TTM)||-41.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Bothell, Washington-based company said it had a loss of 39 cents per share. The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research ...
The Zacks Analyst Blog Highlights: Merck, Celgene, Gilead Sciences, Seattle Genetics and Vanda Pharmaceuticals
The NYSE ARCA Pharmaceutical Index has risen almost 9.8% year to date.